当前位置：首页 > 文献互助 > 互助详情

期刊论文Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study复制

用户EO9nReo4Hj6s 1小时前 9 待确认帖子自动结束时间: 2026-07-22 10:50:26

1. 请及时下载文件确认是否正确, 系统将在 2026-07-24 11:07:45 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1080/1120009x.2026.2684301复制

文献链接: https://www.tandfonline.com/doi/full/10.1080/1120009X.2026.2684301复制

其他信息:

出版社: Informa UK Limited
作者: Tiegang Li

上一篇：Biomimetic Shell–Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer

下一篇：Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial

互助时间线

2026-07-17 11:07:45 [上传文件]

小小乐园上传了文件(pdf 1.37 MB), 求助状态变成待确认

2026-07-17 10:50:26 [发起求助]

最新发布的求助

Effectiveness of Mepolizumab on Mucus Plug Reduction and Clinical Outcomes in Severe Eosinophilic Asthma: A Prospective Observational Study 18秒前

Long-term safety and efficacy of intracortical microstimulation in humans 36分钟前

等离子表面改性实现原位生长高分辨率钙钛矿发光二极管 53分钟前

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial 1小时前

Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study 1小时前

Biomimetic Shell–Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer 1小时前

Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis 1小时前

Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial 1小时前

First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer 1小时前

Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial 1小时前

Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer 1小时前

Efficacy and Safety of Fibroblast Growth Factor 21 (FGF21) Analogs in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction … 1小时前